Crystallographic and molecular-orbital studies on the geometry of antifolate drugs.
In the common dihydrofolate reductase inhibitors an amino substituent replaces the pteridine carbonyl oxygen atom of folates, with altered hydrogen-bonding properties and size. Flexibility in the amino groups could facilitate enzyme binding. Studies of cycloguanil hydrochloride by neutron diffraction show both in-plane and out-of-plane deformation of amino groups. Molecular-orbital calculations ab initio on 2,4-diamino-5-methylpyrimidinium cation confirm that the 4-amino group is readily deformable. The 2,4-diaminoquinazoline structure is reported. Atomic co-ordinates, thermal parameters, bond distances and bond angles for cycloguanil and 2,4-diaminoquinazoline have been deposited as Supplementary Publication SUP 50108 (13 pages) at the British Library Lending Division, Boston Spa. Wetherby, West Yorkshire LS23, 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1978) 169, 5.
D055598:Chemical Phenomena; D002621:Chemistry; D003461:Crystallography; D005493:Folic Acid Antagonists; D002727:Proguanil; D011743:Pyrimidines; D011799:Quinazolines; D014227:Triazines
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D011799:Quinazolines; D014227:Triazines; C026010:2,4,6-triamino-5-chloroquinazoline; C026008:2,4-diamino-5-methylpyrimidine; C013474:2,4-diaminoquinazoline; C026009:cycloguanil; D002727:Proguanil